Exagen Inc. (XGN) - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K reports the results of Exagen Inc.'s 2025 Annual Meeting of Stockholders held on June 10, 2025. The filing details the final voting outcomes for four proposals regarding director elections, auditor ratification, and executive compensation.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting results.
Material Changes and Voting Results
Stockholders voted on four proposals with the following outcomes:
- Proposal 1 (Director Election): Stockholders elected two Class III directors for a three-year term expiring in 2028.
- John Aballi: 8,593,115 votes For; 32,626 votes Withheld.
- Bruce C. Robertson, Ph.D.: 5,656,283 votes For; 2,969,458 votes Withheld.
- Proposal 2 (Auditor Ratification): Stockholders ratified the appointment of BDO USA, P.C. as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
- Result: 11,532,748 votes For; 74,611 votes Against.
- Proposal 3 (Say-on-Pay): Stockholders approved the advisory vote on named executive officer compensation.
- Result: 8,599,414 votes For; 16,752 votes Against.
- Proposal 4 (Say-on-Pay Frequency): Stockholders approved holding future advisory votes on executive compensation annually.
- Result: 8,376,265 votes for 1 Year; 86,357 votes for 2 Years; 155,681 votes for 3 Years.
Guidance, Outlook, and Management Commentary
Consistent with the Board's recommendation, the Company will hold an advisory vote on executive compensation every year until the next required vote on frequency. No financial guidance, risk factors, or unusual items were disclosed in this specific filing.
Investor Verification Checklist
- Verify the significant number of votes withheld for director Bruce C. Robertson, Ph.D. (approx. 35% of votes cast).
- Review the definitive Proxy Statement (Schedule 14A) filed on April 30, 2025, for detailed biographies of the elected directors and executive compensation specifics.
- Confirm the Company's financial status in the most recent 10-K or 10-Q, as this 8-K contains no financial data.